Search

Certara Inc

Chiusa

SettoreSettore sanitario

8.49 0.95

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

8.25

Massimo

8.44

Metriche Chiave

By Trading Economics

Entrata

-380K

-9.1M

Vendite

-14M

93M

P/E

Media del settore

100.714

56.432

EPS

0.05

Margine di Profitto

-9.803

Dipendenti

1,515

EBITDA

-4.2M

12M

Raccomandazioni

By TipRanks

Raccomandazioni

Neutrale

Previsioni per 12 mesi

-3.8% downside

Dividendi

By Acuity

Utili prossimi

5 nov 2026

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

-52M

1.2B

Apertura precedente

7.54

Chiusura precedente

8.49

Notizie sul Sentiment di mercato

By Acuity

50%

50%

106 / 339 Classifica in Healthcare

Certara Inc Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

18 set 2026, 20:07 UTC

Certara Inc's stock is declining, having pulled back from an earlier peak, and remains lower compared to Thursday's close while trading above its 20-day moving average.

17 set 2026, 23:31 UTC

Certara Inc is rising in after-market trading, reaching a peak shortly after the market closed, significantly above its 20-day moving average.

16 set 2026, 22:01 UTC

Certara Inc is seeing a slight uptick in after-market trading, recovering from a brief dip to achieve a modest gain within its one-month trading range.

15 set 2026, 20:01 UTC

Certara Inc shares are higher during Tuesday's session, diverging from broader market sentiment impacted by a decline in the NY Empire State Manufacturing Index.

14 set 2026, 19:51 UTC

Certara Inc shares are trading higher, continuing a recent upward trend. No specific news was identified to explain this price movement.

10 set 2026, 20:07 UTC

Shares of Certara Inc. are trading lower today, reflecting broader market trends amid five consecutive sessions of declines and pressure from recent interest rate hikes.

9 set 2026, 20:07 UTC

Certara Inc. shares are lower today, breaking the upward trend seen since Tuesday's close. No specific news or development was identified.

8 set 2026, 19:41 UTC

Certara Inc is lower today, impacted by weakness in the Health Care Technology sub-sector. The stock remains below its 20-day moving average.

3 set 2026, 20:07 UTC

Certara Inc shares are lower today, continuing a decline since Wednesday amid a broader downturn in the health care technology sector.

1 set 2026, 20:08 UTC

Certara Inc shares are lower today, continuing a downward trend from earlier sessions and remaining below the 20-day moving average.

31 ago 2026, 22:02 UTC

Shares of Certara Inc. are trading lower during after-market hours, reversing a trend of higher daily closes. No specific news was identified.

27 ago 2026, 20:01 UTC

Certara Inc shares are higher today, continuing an upward trend since Wednesday. Broader market sentiment may be influenced by declining initial jobless claims.

26 ago 2026, 19:56 UTC

Shares of Certara Inc. are modestly higher today, reflecting typical intraday fluctuations. No specific company news was identified to explain the move.

25 ago 2026, 20:51 UTC

Certara Inc shares are higher in after-market trading, continuing a rise since Tuesday's close amid favorable market conditions and lower U.S. Treasury yields.

24 ago 2026, 20:01 UTC

Certara Inc shares are lower today, continuing a decline since Friday's close amid broader market pressures and geopolitical concerns affecting oil supply and inflation.

21 ago 2026, 19:56 UTC

Certara Inc shares are lower today, continuing a decline since Thursday. The stock is significantly below its 20-day moving average.

20 ago 2026, 20:06 UTC

Certara Inc shares are higher during Thursday's session, reflecting broader market dynamics and notable increases in U.S. Treasury yields and crude oil prices.

19 ago 2026, 23:56 UTC

Certara Inc. shares are lower in after-hours trading, showing slight declines since Wednesday's close while remaining above the 20-day moving average.

18 ago 2026, 19:36 UTC

Certara Inc. is trading higher during Tuesday's session, maintaining routine performance within a narrow range above its 20-day moving average.

13 ago 2026, 19:41 UTC

Certara Inc is rising, supported by strength in the Health Care Technology sub-sector, despite a slight pullback from earlier session highs.

12 ago 2026, 19:46 UTC

News

Certara shares are lower as Jefferies raises the price target to $7.45 from $6.00 while maintaining a Hold rating.

11 ago 2026, 23:51 UTC

Certara Inc is higher in after-hours trading, reflecting strong momentum and robust interest following notable activity earlier in the session.

7 ago 2026, 19:26 UTC

Certara Inc shares are higher today, maintaining a positive trajectory since Thursday. The stock remains above its 20-day moving average.

6 ago 2026, 20:02 UTC

News

Certara Inc is rising today, driven by strength in the Health Care Technology sub-sector. The stock remains above its 20-day moving average.

5 ago 2026, 20:13 UTC

Certara Inc shares are lower in after-market trading amid broader market fluctuations and rising gold prices, reflecting ongoing geopolitical tensions.

4 ago 2026, 20:03 UTC

News

Certara reported a second-quarter net loss of $6.1 million and lowered its full-year guidance, contributing to a decline in shares during today's session.

3 ago 2026, 19:26 UTC

News

Certara Inc shares are higher, supported by gains in the Health Care Technology sector. The company will report Q2 2026 results on August 4.

31 lug 2026, 19:26 UTC

Certara Inc shares are higher today, recovering from an early dip and trading near the top of their one-month range. No specific news was identified.

30 lug 2026, 19:58 UTC

Certara Inc is lower amid Health Care Technology sub-sector weakness. The stock reversed an early gain and remains above its 20-day moving average.

29 lug 2026, 18:53 UTC

Health Care Technology sector strength is lifting Certara Inc during Wednesday's session. The asset remains above its 20-day moving average, marking six straight days of gains.

Confronto tra pari

Modifica del prezzo

Certara Inc Previsione

Obiettivo di Prezzo

By TipRanks

-3.8% in calo

Previsioni per 12 mesi

Media 8.1 USD  -3.8%

Alto 9 USD

Basso 7 USD

Basato su 7 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Certara Inc - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Neutrale

7 ratings

1

Acquista

6

Mantieni

0

Vendi

Sentiment

By Acuity

106 / 339 Classifica in Settore sanitario

Notizie sul Sentiment di mercato

Neutral

Volatilità

Sotto la media

Volume delle notizie (RCV)

Sotto la media

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo Certara Inc

Certara, Inc., together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the United States and internationally. It offers solutions for model-informed drug development, as well as biosimulation solution used to predict both pharmacokinetics and pharmacodynamics. The company provides Simcyp Simulator, a mechanistic biosimulation platform mechanistic biosimulation investigational new drug and translational stages; Simcyp Biopharmaceutics, used to identify and refine drug formulations; and Simcyp Secondary Intelligence which integrates toxicology with quantitative analysis of networks of molecular and functional biological changes to identify drug toxicity and adverse drug reactions. In addition, it offers Phoenix WinNonlin, a platform for non-compartmental analysis, pharmacokinetic/pharmacodynamic, and toxicokinetic; phoenix hosted, that provides a secured and validated certara amazon web services workspace; Phoenix NLME, a population modeling and simulation software for nonlinear mixed effects models; and pirana modeling workbench. Further, the company provides pinnacle 21, a cloud-based platform for clinical data automation, standardization, and validation; Pinnacle 21 Data Exchange, used to define data standards and specifications; and Metadata Repository, to enable study design using controlled and standardized data. It serves life sciences companies, biopharmaceutical companies, research organizations, academic institutions, and global regulators, as well as animal health, crop science, bio science, medical devices, and public sector industries. Certara Inc. was founded in 2008 and is headquartered in Princeton, New Jersey.